SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-224125
Filing Date
2022-08-18
Accepted
2022-08-18 16:15:56
Documents
14
Period of Report
2022-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d386166d8k.htm   iXBRL 8-K 30459
2 EX-10.1 d386166dex101.htm EX-10.1 24722
3 EX-10.2 d386166dex102.htm EX-10.2 74951
  Complete submission text file 0001193125-22-224125.txt   266031

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atnx-20220814.xsd EX-101.SCH 2858
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20220814_lab.xml EX-101.LAB 17996
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20220814_pre.xml EX-101.PRE 11263
8 EXTRACTED XBRL INSTANCE DOCUMENT d386166d8k_htm.xml XML 3338
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38112 | Film No.: 221177671
SIC: 2834 Pharmaceutical Preparations